| scholarly article | Q13442814 |
| P2093 | author name string | Zheng Wang | |
| Yang Guan | |||
| Sheng-Hong Liu | |||
| You-Bing Ruan | |||
| P2860 | cites work | M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity | Q28284646 |
| Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis | Q30795727 | ||
| De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma | Q31938591 | ||
| The IGF axis and hepatocarcinogenesis | Q33918694 | ||
| A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. | Q34124264 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis. | Q36491997 | ||
| Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis | Q36586442 | ||
| CEA and AFP expression in human hepatoma cells transfected with antisense IGF-I gene | Q38634607 | ||
| SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. | Q40749632 | ||
| Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma | Q40775362 | ||
| Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma | Q40907324 | ||
| Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis. | Q40941257 | ||
| Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: measurement by enzyme-linked immunosorbent assay | Q40972971 | ||
| The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells | Q41119539 | ||
| Detection of blood AFPmRNA in nude mice bearing human HCC using nested RT-PCR and its significance | Q41840365 | ||
| Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study | Q42506078 | ||
| Clinical significance of serum intercellular adhesion molecule-1 detection in patients with hepatocellular carcinoma | Q43119012 | ||
| Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma | Q43799501 | ||
| Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma | Q44648430 | ||
| Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression | Q45783000 | ||
| Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II. | Q53438893 | ||
| Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel | Q57006279 | ||
| Serum insulin-like growth factor II in chronic liver disease | Q69332004 | ||
| Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats | Q73002025 | ||
| Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia | Q73292299 | ||
| The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis | Q73434317 | ||
| [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis] | Q73910819 | ||
| Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma | Q74093462 | ||
| u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma | Q74108509 | ||
| Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan | Q77807971 | ||
| Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma | Q77916708 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 267-270 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis | |
| P478 | volume | 9 |
| Q38166571 | An Overview of Biomarkers and Molecular Signatures in HCC. |
| Q38751864 | Antisense oligonucleotides directed against insulin-like growth factor-II messenger ribonucleic acids delay the progress of rat hepatocarcinogenesis |
| Q37534945 | Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring |
| Q86880133 | Complexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumor |
| Q28069313 | Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma |
| Q40164544 | Gene regulation networks related to neural differentiation of hESC. |
| Q43141124 | Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer |
| Q39324518 | HBV regulated RhoC expression in HepG2.2.15 cells by enhancing its promoter activity |
| Q36180508 | Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line |
| Q52558393 | Insulin-Like Growth Factor (IGF) System in Liver Diseases. |
| Q30445881 | Invasion and metastasis models for studying RhoGDI2 in bladder cancer |
| Q46300666 | Polymorphism in IGF-2 as a surrogate marker for predisposition towards tobacco chewing-mediated oral cancer |
| Q38030991 | Potential for statins in the chemoprevention and management of hepatocellular carcinoma |
| Q37113552 | Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. |
| Q37859024 | Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer |
| Q42635172 | Targeted medical therapy of biliary tract cancer: recent advances and future perspectives |
| Q37650623 | Targeted therapy in biliary tract cancer: 2009 update. |
| Q33951057 | Targeting insulin-like growth factor axis in hepatocellular carcinoma |
| Q43097453 | Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives |
Search more.